COSCIENS Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 156.7%.

Top 23 shareholders own 6.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.84%	GoodWood Inc.	178,680	US$954.4k	0%	23.23%
0.98%	Gilles Gagnon	36,062	US$192.6k	0%	no data
0.16%	Prodev Pharma Inc	5,900	US$31.5k	0%	no data
0.11%	Morgan Stanley, Investment Banking and Brokerage Investments	4,045	US$21.6k	0%	no data
0.11%	Citadel Advisors LLC	3,960	US$21.2k	0%	no data
0.075%	BMO Asset Management Corp.	2,770	US$14.8k	0%	no data
0.065%	William Li	2,397	US$12.8k	0%	no data
0.064%	1832 Asset Management L.P.	2,360	US$12.6k	0%	no data
0.05%	Ulrich Kosciessa	1,848	US$9.9k	0%	no data
0.025%	Geode Capital Management, LLC	939	US$5.0k	3.19%	no data
0.023%	National Bank Investments Inc.	844	US$4.5k	0%	no data
0.021%	Stacy Prefontaine	767	US$4.1k	0%	no data
0.013%	Carolyn Egbert	469	US$2.5k	0%	no data
0.0087%	Dennis Turpin	320	US$1.7k	0%	no data
0.0031%	RBC Dominion Securities Inc., Asset Management Arm	115	US$613.8	0%	no data
0.0014%	Osaic Wealth, Inc. , Asset Management Arm	50	US$266.4	0%	no data
0.00095%	Tower Research Capital Europe Limited	35	US$187.5	0%	no data
0.0007%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	26	US$138.2	0%	no data
0.0006%	Truvestments Asset Management LLC	22	US$118.4	0%	no data
0.00054%	Bank of America Corporation, Asset Management Arm	20	US$106.6	0%	no data
0.00041%	Citigroup Inc.,Banking and Securities Investments	15	US$80.9	0%	no data
0.00027%	JPMorgan Chase & Co, Brokerage and Securities Investments	10	US$53.3	-94.5%	no data
0.00005%	Planning Capital Management Corp.	2	US$9.9	0%	no data